---
title: Comparison of the clinical chemistry score to other biomarker algorithms for
  rapid rule-out of acute myocardial infarction and risk stratification in patients
  with suspected acute coronary syndrome
date: '2024-01-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38278492/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240127170650&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The CCS ensures reliable AMI rule-out with low short and
  long-term outcome rates for a specific ED patient subset. However, compared to a
  single or dual biomarker strategy, the CCS displays reduced efficacy and specificity,
  limiting its clinical ...'
disable_comments: true
---
CONCLUSIONS: The CCS ensures reliable AMI rule-out with low short and long-term outcome rates for a specific ED patient subset. However, compared to a single or dual biomarker strategy, the CCS displays reduced efficacy and specificity, limiting its clinical ...